REFLECT: Reproductive Education and Fertility Links for Cancer Treatment

Recruiting

• Conditions: Reproductive Behavior

• Registration Number: NCT06199726
• Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Brief Summary

The purpose of this study is to evaluate a web-based education tool geared at helping Adolescent and Young Adult (AYA) patients better understand fertility and genetic risks for cancer in future offspring.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-11
• Study First Submitted: 2023-12-28
• Study First Submitted QC: 2023-12-28
• Study First Posted: 2024-01-10
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-13
• Last Update Posted: 2025-05-14
• Primary Completion: 2025-12-05
• Study Completion: 2026-12-05

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• Adults between the ages of 18-39
• Must have received Cancer care at Moffitt Cancer Center
• Participants must consider having a child in the future or have had children at the time of diagnosis
• Participants must be able to speak and read English
• Participants must have access to a device that can connect to the internet

Exclusion Criteria

• Any participants who do not meet all Inclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Confidence in use of the REFLECT tool	One Year	System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)
Complexity of use of the REFLECT tool	One Year	System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)
Desire to use the REFLECT tool	One Year	System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)
Perception of inconsistencies of the REFLECT tool	One Year	System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)
Ease of use of the REFLECT tool	One Year	System usability scale of 1-5 (1 strongly disagree and 5 strongly agree)

Trial Locations

Locations (1)

Moffitt Cancer Center; 🇺🇸 Tampa, Florida, United States